« Back to Record
Bernardino, J. I., Mocroft, A., Mallon, P. W., Wallet, C., Gerstoft, J., Russell, C., Reiss, P., Katlama, C., De Wit, S., Richert, L., Babiker, A., Buño, A., Castagna, A., Girard, P. M., Chêne, G., Raffi, F., Arribas Lopez, J. R., & NEAT001/ANRS143 Study Group, (2015). Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial. The lancet. HIV, 2(11), e464-e473. doi:10.1016/S2352-3018(15)00181-2
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/224474



